Prognosis

Bavarian Nordic May Sell Its Covid Vaccine Candidate, JP Reports

Provide news feedback or report an error

Confidential tip?

Send a tip to our reporters

Site feedback:

Take our Survey

By Hanna Hoikkala

June 19, 2021 at 8:24 AM UTC

This article is for subscribers only.

Sign up here for our daily coronavirus newsletter on what you need to know

Biotechnology company Bavarian Nordic A/S may sell its Covid-19 vaccine candidate if it can’t raise the money needed to carry out trials on humans, Jyllands-Posten reported.